» Articles » PMID: 32355526

Clear Cell Sarcoma of the Kidney in Children: a Clinopathologic Analysis of Three Cases

Overview
Specialty Pathology
Date 2020 May 2
PMID 32355526
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Clear cell sarcoma of the kidney (CCSK) is a rare malignant tumor in children with uncertain histologic and immunohistologic traits. It mostly reveals atypical clinical symptoms similar to other familiar pediatric renal neoplasms, including abdominal mass, abdominal pain, hematuria, etc. Therefore, the lack of specificity in clinical symptoms may induce some challenging and controversial diagnoses.

Methods: Three cases of CCSK were acquired data from the First Affiliated Hospital of Bengbu Medical College (China) in recent years, accompanied by clinical symptoms and imaging manifestations without obvious specificity, while abdominal mass and abdominal pain were described as the main manifestations; even the initial clinical diagnosis of one case was Wilms Tumor (WT). Two of them underwent a radical nephrectomy. All 3 cases were detected by hematoxylin-eosin (H&E) staining and immunohistochemistry.

Results: Microscopic examination demonstrated the tumor component consisted of loose, locally dense tumor stroma and parenchyma composed of round or oval cells, which were separated by dendritic fibrosis. Afterwards, the unified immunophenotype were positive for Cyclin D1, Bcl-2, Vimentin, SATB-2, α-AACT, and Ki-67 (+, 30%, 40% and 80%, respectively).

Conclusion: Pathologic diagnosis of the disease should be comprehensively analyzed by multiple methods. More abundant morphologic, immunohistological, clinical and radiologic data can contribute to rigorous diagnosis and more accurate clinical treatment.

Citing Articles

CT radiomics to differentiate between Wilms tumor and clear cell sarcoma of the kidney in children.

Deng Y, Wang H, He L BMC Med Imaging. 2024; 24(1):13.

PMID: 38182986 PMC: 10768092. DOI: 10.1186/s12880-023-01184-2.


Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK).

Fiore M, Taddia A, Indio V, Bertuccio S, Messelodi D, Serravalle S Int J Mol Sci. 2023; 24(4).

PMID: 36835166 PMC: 9964999. DOI: 10.3390/ijms24043743.

References
1.
Royer-Pokora B . Genetics of pediatric renal tumors. Pediatr Nephrol. 2012; 28(1):13-23. DOI: 10.1007/s00467-012-2146-4. View

2.
Zekri W, Alfaar A, Yehia D, Elshafie M, Zaghloul M, El-Kinaai N . Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries. Pediatr Blood Cancer. 2014; 61(12):2185-90. DOI: 10.1002/pbc.25192. View

3.
Hadley G, Sheik-Gafoor M . Clear cell sarcoma of the kidney in children: experience in a developing country. Pediatr Surg Int. 2010; 26(4):345-8. DOI: 10.1007/s00383-010-2554-0. View

4.
Furtwangler R, Gooskens S, van Tinteren H, de Kraker J, Schleiermacher G, Bergeron C . Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer. 2013; 49(16):3497-506. DOI: 10.1016/j.ejca.2013.06.036. View

5.
OMeara E, Stack D, Lee C, Garvin A, Morris T, Argani P . Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. J Pathol. 2012; 227(1):72-80. DOI: 10.1002/path.3985. View